[Skip to Content]
[Skip to Content Landing]
Citations 0
December 18, 2002

Relationships Between Pharmaceutical and Tobacco Companies

Author Affiliations

Stephen J.LurieMD, PhD, Senior Editor


Not Available

JAMA. 2002;288(23):2973. doi:10.1001/jama.288.23.2973-JLT1218-5-3

In Reply: As we noted in our article, CIBA-Geigy became Novartis on March 7, 1996, and the industry documents on the marketing of Habitrol were dated earlier. The tobacco industry documents released in the 1998 Master Settlement Agreement contain relatively little information on JT. We thank Dr Kawane for sharing the example regarding JT. His letter points out that conflicts of interest resulting from corporate diversification and financial ties among tobacco and other companies are a global problem.

First Page Preview View Large
First page PDF preview
First page PDF preview